Regeneron Pharmaceuticals, Inc. (REGN) Free Cash Flow
Regeneron Pharmaceuticals, Inc. (REGN) free cash flow history and trends. Track FCF in Excel with MarketXLS.
Free Cash Flow Data
| Period | Free Cash Flow (USD) |
|---|---|
| 2016-12-31 | $961.46M |
| 2017-12-31 | $1.03B |
| 2018-12-31 | $1.81B |
| 2019-12-31 | $2.00B |
| 2020-12-31 | $2.00B |
| 2021-12-31 | $6.53B |
| 2022-12-31 | $3.40B |
| 2023-12-31 | $3.88B |
| 2024-12-31 | $3.66B |
| 2025-12-31 | $4.08B |
How REGN compares with sector peers
| Symbol | Company | Free cash flow (latest fiscal year) |
|---|---|---|
| VRTX | Vertex Pharmaceuticals Incorporated | $3.19B |
| BDX | Becton Dickinson and Company | $2.67B |
| ZTS | Zoetis Inc. Class A | $2.28B |
| IQV | IQVIA Holdings Inc. | $2.05B |
| VTRS | Viatris Inc. | $1.94B |
These are five companies in the same sector as REGN with a comparable annual free cash flow. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Regeneron Pharmaceuticals, Inc. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Free_Cash_Flow("REGN", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | REGN | $823.82 | +3.10% | 0.68M |
| 3 | ||||
| 4 | ||||
| 5 |